Stefan Laufer
0000-0001-6952-1486
Eberhard Karls Universität Tübingen
26 papers found
Refreshing results…
Discovery and Evaluation of Enantiopure 9H-pyrimido[4,5-b]indoles as Nanomolar GSK-3β Inhibitors with Improved Metabolic Stability
The European Federation for Medicinal Chemistry (EFMC) Best Practice Initiative: Validating Chemical Probes
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
Development, Optimization, and Structure–Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-d]pyrrolo[2,3-b]pyridine Scaffold
Discovery of N-{4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a Dual p38α MAPK/PDE-4 Inhibitor with Activity against TNFα-Related Diseases
Missing publications? Search for publications with a matching author name.